[The efficacy of using low doses of immunomodulators for treating experimental tumors].

The data about the ability of various substances to cause definite reactions in biological objects are adduced, and, in particular, about the efficacy of a small doses of antitumoral chemopreparations in experiment. The results of investigation of the application efficacy of various doses of immunomodulating agents, such as arbisol, nucleoplat, the substrate from gram-negative bacteria Yersinia enterocolitica, antitumoral vaccine from the tumoral cells are presented for the cancer chemotherapy. While application of super-small doses of an antitumoral vaccine there was noted statistically significant inhibition of tumoral growth.

[Immune reaction to the heterologic test-antigen in mice with anti-cancer vaccine].

The stimulated influence of the antitumoral vaccine, prepared with the help of filtrate of the Bacillus mesentericus AB-56 or the antibiotic, extracted from it, on the immune answer to heterologic test-antigen (ram erythrocytes) was established. While the vaccine injection to laboratory animals with developing tumor their capacity to resist to the tumors was rising up.

[Results and the prospects of use of the new chemical preparation polyplatillene with antineoplastic and antiviral properties].

Ten years experience of the polyplatillene clinical application and experimental study is summarized. Results of treatment of 689 inner organs cancer patients stage IV, I-IV clinical groups. The advantages of polyplatillene versus others platinum group chemopreparations are shown.